Compugen | CGEN - Debt


Compugen reported $3.02M in Debt for its fiscal quarter ending in June of 2026.





Debt Change Date
Arca Biopharma USD 0 0 Mar/2025
aTyr Pharma USD 2.28M 478K Jun/2026
Bio Path USD 261K 261K Mar/2025
Brainstorm Cell Therapeutics USD 1.2M 1.2M Mar/2025
Cara Therapeutics USD 0 0 Mar/2025
Clal Biotechnology ILS 35.76M 28.27M Dec/2023
Compugen USD 3.02M 91K Jun/2026
Immunic USD 0 0 Jun/2024
Minerva Neurosciences USD 0 0 Sep/2024
RedHill Biopharma USD 214K 142K Jun/2025
TherapeuticsMD USD 93.6M 2.82M Sep/2022